Ophthalmoplegia, also referred as extra ocular muscle palsy, is a paralysis of the extra ocular muscles that control movements of eyes. In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged. A number of devices and treatments are available in the market, which can cure or improve the eyesight of the patient. The Global Ophthalmoplegia Market is driven by increasing number of people with ophthalmoplegia and increasing geriatric population. According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80% people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries. Increasing prevalence of eye sight affecting diseases, for instance, diabetes and rapid developments in technology have fuelled the growth of the market. On the other hand, high cost of the treatment and availability of cheap alternative treatment may slow the growth of the market.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
Ophthalmoplegia Market Top Key Players:
Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant Pharmaceuticals International, Inc. (US), Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson (US).
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/4216
Ophthalmoplegia Market Segments:
The global Ophthalmoplegia Market has been segmented on the basis of type, treatment and end user.
On the basis of types, the market is segmented into external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia is further segmented into superior recti, inferior recti, medial recti, lateral recti, inferior oblique, and superior oblique muscles.
On the basis of treatment, the market is segmented into surgery, drug treatment, and others. The surgery is further segmented into strabismus surgery and others.
On the basis of end users, the market is segmented into hospital & clinics, ambulatory clinics, and others.
Ophthalmoplegia Market Regional analysis:
The Americas dominates the global Ophthalmoplegia Market owing to well-developed technology and increased patient population with eye sight problem primarily due to increasing prevalence of diabetes. Additionally, high healthcare expenditure and the presence of some of the leading players have fuelled the growth of the market in this region.
Europe is the second largest Ophthalmoplegia Market, which is followed by Asia Pacific. Increasing government support and availability of funds for research drive the growth of the market. Asia Pacific is the fastest growing Ophthalmoplegia Market due to increasing geriatric population and rapidly developing medical sector.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities and poor economic and political conditions in Africa.

Research Methodology:
The report for the global Ophthalmoplegia Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Table of Content
1 Report Prologue

2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Ophthalmoplegia Market, By Types
7 Global Ophthalmoplegia Market, By Treatments
8 Global Ophthalmoplegia Market, By End Users
9 Global Ophthalmoplegia Market By Region
10 Company Landscape
11 Company Profiles
12 MRFR Conclusion
…Continued
Get Discount @ https://www.marketresearchfuture.com/check-discount/4216 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]